Meloxicam Inhibits Hepatocellular Carcinoma Progression and Enhances the Sensitivity of Immunotherapy via the MicroRNA-200/PD-L1 Pathway - Concepedia

Concepedia

Publication | Open Access

Meloxicam Inhibits Hepatocellular Carcinoma Progression and Enhances the Sensitivity of Immunotherapy via the MicroRNA-200/PD-L1 Pathway

DOI Full Paper Access

10

Citations

19

References

2022

Year

Guangshun Sun, Guoqiang Sun, Xin Chen, Xiangyi Kong, Wubin Zheng, Zhitao Li, Zheng Zhiying, Hongyong Cao, Chengyu Lv, Yongxiang Xia,

Journal of Oncology

Abstract

Our study showed meloxicam inhibited HCC progression and enhanced the sensitivity of immunotherapy via the microRNA-200/PD-L1 pathway.

References

	Year	Citations

Page 1